Becker's ASC: FDA approves Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System — 4 insights
The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
FDA approves Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System — 4 insights
Becker's ASC: Boston Scientific Receives CE Mark for Precision Plus Spinal Cord Stimulator
Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...
FinanzNachrichten.de: Spinal Cord Stimulation Devices Market to Reach $4.8 Billion by 2032; Chronic Pain Demand Drives 8.4% CAGR | Allied Market Research
Spinal Cord Stimulation Devices Market to Reach $4.8 Billion by 2032; Chronic Pain Demand Drives 8.4% CAGR | Allied Market Research
FierceBiotech: Boston Scientific to drop $533M to acquire neurostimulator maker Nalu Medical